Alessandro Arcucci

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Correction: Uridine diphosphate drives myeloid differentiation and functional reprogramming through dynamic transcriptional network.

Correction: Uridine diphosphate drives myeloid differentiation and functional reprogramming through dynamic transcriptional network.

Journal: Frontiers in immunology

Published: February 14, 2026

Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies.

Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies.

Journal: Frontiers in immunology

Published: November 25, 2025

Uridine diphosphate drives myeloid differentiation and functional reprogramming through dynamic transcriptional network.

Uridine diphosphate drives myeloid differentiation and functional reprogramming through dynamic transcriptional network.

Journal: Frontiers in immunology

Published: November 10, 2025

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma.

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma.

Journal: Communications biology

Published: March 05, 2024

Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment.

Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment.

Journal: International journal of molecular sciences

Published: February 20, 2024

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

Journal: Frontiers in oncology

Published: November 17, 2023

Celecoxib, a Non-Steroidal Anti-Inflammatory Drug, Exerts a Toxic Effect on Human Melanoma Cells Grown as 2D and 3D Cell Cultures.

Celecoxib, a Non-Steroidal Anti-Inflammatory Drug, Exerts a Toxic Effect on Human Melanoma Cells Grown as 2D and 3D Cell Cultures.

Journal: Life (Basel, Switzerland)

Published: March 21, 2023

The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages.

The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages.

Journal: International journal of molecular sciences

Published: July 29, 2022

Thyroid Cancer and Fibroblasts.

Thyroid Cancer and Fibroblasts.

Journal: Cancers

Published: July 15, 2022

Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.

Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.

Journal: International journal of molecular sciences

Published: May 06, 2022

Insights into Melanoma Fibroblast Populations and Therapeutic Strategy Perspectives: Friends or Foes?

Insights into Melanoma Fibroblast Populations and Therapeutic Strategy Perspectives: Friends or Foes?

Journal: Current medicinal chemistry

Published: March 21, 2022

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance.

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance.

Journal: Frontiers in cell and developmental biology

Published: March 14, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026